BNTC Operating Cash Flow Growth
Benitec Biopharma Inc · Operating Cash Flow Growth
BNTC Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported28.97%period ending
BNTC TTM Cash from Operations YoY % (-249.82% → 28.97%)
Year-over-year change
High-resolution chart · PNG
BNTC operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 28.9738% | |
| -10.1749% | |
| 14.1069% | |
| -16.547% | |
| -22.9535% | |
| 6.5876% | |
| -22.7496% | |
| -7.4959% | |
| -10.701% | |
| -8.3599% | |
| 0.3359% | |
| -16.5235% | |
| -11.4255% | |
| -13.8368% | |
| -20.7726% | |
| -5.2753% | |
| -22.8265% | |
| -49.732% | |
| -49.3923% | |
| -53.1754% | |
| -58.903% | |
| -43.6293% | |
| -52.5782% | |
| -85.6944% | |
| -538.9846% | |
| -304.9546% | |
| -64.8392% | |
| 19.2587% | |
| 89.5887% | |
| 83.2982% | |
| 43.3818% | |
| -1.639% | |
| -46.1774% | |
| -41.7609% | |
| 50.2437% | |
| 64.1577% | |
| 58.9074% | |
| 65.3082% | |
| 28.053% | |
| -21.9095% | |
| -108.5007% | |
| -219.7499% | |
| -143.8343% | |
| -67.9236% | |
| -4.5416% | |
| 12.7163% | |
| -14.5833% | |
| -79.4345% | |
| -249.8209% |